Novo Nordisk Sues Eli Lilly Over Deceptive GLP-1 Drug Ads
Novo Nordisk on Tuesday sued Eli Lilly for allegedly running a 'deceptive' ad campaign that uses outdated clinical trials to make its obesity and diabetes drugs appear more effective.
Synthesized news with full source attribution.
Novo Nordisk on Tuesday sued Eli Lilly for allegedly running a 'deceptive' ad campaign that uses outdated clinical trials to make its obesity and diabetes drugs appear more effective.